机器人单孔与多孔全子宫切除术联合前哨淋巴结定位治疗子宫内膜癌的手术结局与成本分析比较
回顾性队列研究比较机器人单孔(R-LESS)与多孔(MPR)全子宫切除术联合前哨淋巴结定位治疗复杂不典型增生或低级别子宫内膜癌。两组手术时间、出血量及并发症无显著差异,R-LESS平均总住院费用较低(13,410美元 vs 15,952美元,p<.05)。作者认为R-LESS围手术期结局相当且更具成本效益,需进一步研究。
要点
- R-LESS与MPR组中位手术时间(175 vs 184分钟,p=.61)及控制台时间(136 vs 140分钟,p=.12)相当。
- R-LESS组双侧前哨淋巴结定位成功率85.7%,MPR组76.9%。
- R-LESS平均总住院费用低于MPR(13,410 vs 15,952美元,p<.05)。
核心结论
- 在高度选择的复杂不典型增生或低级别子宫内膜癌患者中,R-LESS行全子宫切除术联合前哨淋巴结定位的围手术期结局似乎与MPR相当,且更具成本效益。
- 需要进一步研究以确定R-LESS在妇科肿瘤领域的获益。
研究设计与样本
- 回顾性队列研究(加拿大任务组分类II-2),在学术性大学医院开展。
- 纳入2012年至2016年间体重指数<30 kg/m²、活检证实为复杂不典型增生或低级别(1或2级)子宫内膜癌并接受机器人全子宫切除术及前哨淋巴结定位的患者。
- 共27例符合标准,其中R-LESS组14例,MPR组13例。
主要发现
- 中位子宫重量两组相当(111.3 g vs 83.8 g;p=.33)。
- 中位手术时间R-LESS组175分钟 vs MPR组184分钟(p=.61),中位控制台时间136分钟 vs 140分钟(p=.12)。
- 两组中位估计出血量均为50 mL。
- 双侧前哨淋巴结定位成功率R-LESS组85.7%,MPR组76.9%。
- 无术中或30天并发症,所有患者均在术后23小时内出院。
关键数值与推荐
- MPR相比R-LESS增加一次性器械和铺巾成本460至660美元,取决于术者器械选择。
- R-LESS平均总住院费用低于MPR(13,410美元 vs 15,952美元;p<.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To compare operative times, surgical outcomes, and costs of robotic laparoendoscopic single-site (R-LESS) vs multiport robotic (MPR) total laparoscopic hysterectomy (TLH) with sentinel lymph node (SLN) mapping for low-risk endometrial cancer. DESIGN: Retrospective cohort study (Canadian Task Force classification II-2). SETTING: Academic university hospital. PATIENTS: Patients with a biopsy-proven diagnosis of complex atypical hyperplasia (CAH) or low-grade (1 or 2) endometrial cancer with body mass index <30 kg/m2 and undergoing robotic TLH and SLN mapping between 2012 and 2016 were included. INTERVENTIONS: Surgical outcomes and cost data were collected retrospectively and analyzed based on the surgical approach with R-LESS vs MPR assistance. MEASUREMENTS AND MAIN RESULTS: Twenty-seven patients who met the inclusion criteria were identified, including 14 patients who underwent R-LESS TLH with SLN mapping and 13 patients who underwent MPR TLH with SLN mapping. Median uterine weight was comparable in the 2 cohorts (111.3 g vs 83.8 g; p = .33). Operative and console times were equivalent with the R-LESS and MPR approaches (median, 175 minutes vs 184 minutes, p = .61 and 136 vs 140 minutes, p = .12, respectively). Median estimated blood loss was 50 mL in both cohorts. Successful bilateral SLN mapping occurred in 85.7% of the R-LESS procedures and 76.9% of MPR procedures. No intraoperative or 30-day complications were encountered, and all patients were discharged within 23 hours of surgery. MPR was associated with additional disposable instrument and drape costs of $460 to $660 compared with R-LESS, depending on the surgeon's instrument selection. Average total hospital charges were lower for R-LESS procedures ($13,410 vs $15,952; p < .05). CONCLUSION: In highly selected patients with CAH or low-grade endometrial cancer undergoing TLH and SLN mapping, R-LESS appears to result in equivalent perioperative outcomes as a MPR approach while offering a more cost-effective option. Further research is needed to determine the benefits of R-LESS procedures in the gynecologic oncology setting.
引用
- Moukarzel LA, Sinno AK, Fader AN, et al. Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis. J Minim Invasive Gynecol. 2017. PMID: 28599884. doi:10.1016/j.jmig.2017.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。